Your browser doesn't support javascript.
loading
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis.
Mor, Adi; Segal Salto, Michal; Katav, Avi; Barashi, Neta; Edelshtein, Victoria; Manetti, Mirko; Levi, Yair; George, Jacob; Matucci-Cerinic, Marco.
Afiliação
  • Mor A; R&D, ChemomAb Ltd, Tel Aviv, Israel.
  • Segal Salto M; R&D, ChemomAb Ltd, Tel Aviv, Israel michal@chemomab.com.
  • Katav A; R&D, ChemomAb Ltd, Tel Aviv, Israel.
  • Barashi N; R&D, ChemomAb Ltd, Tel Aviv, Israel.
  • Edelshtein V; R&D, ChemomAb Ltd, Tel Aviv, Israel.
  • Manetti M; Department of Experimental and Clinical Medicine, Section of Anatomy and Histology, University of Florence, Florence, Italy.
  • Levi Y; Department of Internal Medicine E, Meir Medical Center, Kfar-Saba, Israel.
  • George J; Heart Center, Kaplan Medical Center, Rehovot, Israel.
  • Matucci-Cerinic M; Department of Experimental and Clinical Medicine, University of Florence, Department of Geriatric Medicine, Division of Rheumatology and Scleroderma Unit, AOUC, Florence, Italy.
Ann Rheum Dis ; 78(9): 1260-1268, 2019 09.
Article em En | MEDLINE | ID: mdl-31129606
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Pele / Quimiocina CCL24 / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Pele / Quimiocina CCL24 / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel